• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲乳腺癌的发病率、死亡率及其与发展的关系。

Incidence and Mortality of Breast Cancer and their Relationship to Development in Asia.

作者信息

Ghoncheh Mahshid, Mohammadian-Hafshejani Abdollah, Salehiniya Hamid

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran E-mail :

出版信息

Asian Pac J Cancer Prev. 2015;16(14):6081-7. doi: 10.7314/apjcp.2015.16.14.6081.

DOI:10.7314/apjcp.2015.16.14.6081
PMID:26320499
Abstract

PURPOSE

This study aimed to investigate the incidence and mortality of breast cancer, and its relationship with human development index (HDI) and its components in Asia in 2012.

MATERIALS AND METHODS

This study was an ecologic study in Asia for assessment of the correlation between age-specific incidence rate (ASIR) and age-specific mortality rate (ASMR) with HDI and its details that include: life expectancy at birth, mean years of schooling and gross national income (GNI) per capita. Data about SIR and SMR for every Asian country for the year 2012 were obtained from the global cancer project. We used a bivariate method for assessment of the correlation between SIR and SMR and HDI and its individual components. Statistical significance was assumed if P<0.05. All reported P-values are two-sided. Statistical analyses were performed using SPSS (Version 15.0, SPSS Inc.).

RESULTS

In 2012, 639,824 cases of breast cancer were recorded in Asian countries. Countries with the highest standardized incidence rate (ASIR) (per 100,000) were Israel (80.5), Lebanon (78.7), Armenia (74.1) and the highest standard mortality rate (ASMR) was observed in Pakistan (25.2), Armenia (24.2), and Lebanon (24). There was a positive correlation between the ASIR of breast cancer and HDI (r = 0.556, p <0.001), whereas there was a negative correlation between the ASMR of breast cancer and HDI (r = -0.051).

CONCLUSIONS

Breast cancer incidence in countries with higher development is greater, while mortality is greatest in countries with less development. There was a positive and significant relationship between the ASIR of breast cancer and HDI and its components. Also there was a negative but non significant relationship between the ASMR of breast cancer and HDI.

摘要

目的

本研究旨在调查2012年亚洲乳腺癌的发病率和死亡率,及其与人类发展指数(HDI)及其组成部分的关系。

材料与方法

本研究是一项在亚洲开展的生态学研究,旨在评估特定年龄发病率(ASIR)和特定年龄死亡率(ASMR)与HDI及其详细组成部分(包括:出生时预期寿命、平均受教育年限和人均国民总收入(GNI))之间的相关性。2012年每个亚洲国家的SIR和SMR数据来自全球癌症项目。我们采用双变量方法评估SIR和SMR与HDI及其各个组成部分之间的相关性。若P<0.05,则认为具有统计学意义。所有报告的P值均为双侧。使用SPSS(版本15.0,SPSS公司)进行统计分析。

结果

2012年,亚洲国家共记录了639,824例乳腺癌病例。标准化发病率(ASIR)(每10万)最高的国家是以色列(80.5)、黎巴嫩(78.7)、亚美尼亚(74.1),而标准化死亡率(ASMR)最高的国家是巴基斯坦(25.2)、亚美尼亚(24.2)和黎巴嫩(24)。乳腺癌的ASIR与HDI之间存在正相关(r = 0.556,p <0.001),而乳腺癌的ASMR与HDI之间存在负相关(r = -0.051)。

结论

发展水平较高的国家乳腺癌发病率更高,而发展水平较低的国家死亡率最高。乳腺癌的ASIR与HDI及其组成部分之间存在显著正相关。此外,乳腺癌的ASMR与HDI之间存在负相关,但不显著。

相似文献

1
Incidence and Mortality of Breast Cancer and their Relationship to Development in Asia.亚洲乳腺癌的发病率、死亡率及其与发展的关系。
Asian Pac J Cancer Prev. 2015;16(14):6081-7. doi: 10.7314/apjcp.2015.16.14.6081.
2
Incidence and Mortality of Colorectal Cancer and Relationships with the Human Development Index across the World.全球结直肠癌的发病率、死亡率及其与人类发展指数的关系
Asian Pac J Cancer Prev. 2016;17(5):2465-73.
3
Incidence and Mortality of Breast Cancer and their Relationship with the Human Development Index (HDI) in the World in 2012.2012年全球乳腺癌的发病率、死亡率及其与人类发展指数(HDI)的关系
Asian Pac J Cancer Prev. 2015;16(18):8439-43. doi: 10.7314/apjcp.2015.16.18.8439.
4
Epidemiology and Inequality in the Incidence and Mortality of Nasopharynx Cancer in Asia.亚洲鼻咽癌发病率和死亡率的流行病学与不平等现象
Osong Public Health Res Perspect. 2016 Dec;7(6):360-372. doi: 10.1016/j.phrp.2016.11.002. Epub 2016 Nov 16.
5
Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern.亚洲肾癌的发病率和死亡率以及人类发展指数:一个值得关注的问题。
J Nephropathol. 2017 Jan;6(1):30-42. doi: 10.15171/jnp.2017.06. Epub 2016 Aug 7.
6
The incidence and mortality of ovarian cancer and their relationship with the Human Development Index in Asia.亚洲卵巢癌的发病率、死亡率及其与人类发展指数的关系。
Ecancermedicalscience. 2016 Mar 24;10:628. doi: 10.3332/ecancer.2016.628. eCollection 2016.
7
The Incidence and Mortality of Colorectal Cancer and Its Relationship With the Human Development Index in Asia.亚洲结直肠癌的发病率和死亡率及其与人类发展指数的关系。
Ann Glob Health. 2016 Sep-Oct;82(5):726-737. doi: 10.1016/j.aogh.2016.10.004.
8
The incidence and mortality of prostate cancer and its relationship with development in Asia.亚洲地区前列腺癌的发病率和死亡率及其与发展的关系。
Prostate Int. 2015 Dec;3(4):135-40. doi: 10.1016/j.prnil.2015.09.001. Epub 2015 Sep 25.
9
Incidence and Mortality of Testicular Cancer and Relationships with Development in Asia.亚洲睾丸癌的发病率、死亡率及其与发育的关系。
Asian Pac J Cancer Prev. 2016;17(9):4251-4257.
10
Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide.全球前列腺癌发病率、死亡率及其与人类发展指数的关系
Prostate Int. 2016 Sep;4(3):118-24. doi: 10.1016/j.prnil.2016.07.001. Epub 2016 Jul 25.

引用本文的文献

1
Spatiotemporal disparity of breast cancer incidence in Iranian female populations at the district level from 2000 to 2021: Bayesian disease mapping.2000年至2021年伊朗女性人群乳腺癌发病率在地区层面的时空差异:贝叶斯疾病制图
PLoS One. 2025 Sep 11;20(9):e0330017. doi: 10.1371/journal.pone.0330017. eCollection 2025.
2
Bibliometric Analysis of The Global Research Trends on The Application of Tamoxifen in The Treatment of Breast Cancer Over The Past 50 Years.过去50年他莫昔芬在乳腺癌治疗中应用的全球研究趋势的文献计量分析
Malays J Med Sci. 2025 Feb;32(1):35-55. doi: 10.21315/mjms-06-2024-452. Epub 2025 Feb 28.
3
Predictors of survival among breast cancer patients in Ethiopia: a systematic review and meta-analysis.
埃塞俄比亚乳腺癌患者生存的预测因素:一项系统评价与荟萃分析。
Front Oncol. 2025 Apr 3;14:1459613. doi: 10.3389/fonc.2024.1459613. eCollection 2024.
4
Predictors of survival rates among breast cancer patients in Ethiopia: a systematic review and meta-analysis 2024.埃塞俄比亚乳腺癌患者生存率的预测因素:一项2024年的系统评价与荟萃分析
Arch Public Health. 2025 Feb 6;83(1):30. doi: 10.1186/s13690-025-01514-6.
5
Delayed presentation of breast cancer patients and contributing factors in East Africa: Systematic review and meta-analysis.东非地区乳腺癌患者延迟就诊的表现及相关因素:系统评价和荟萃分析。
PLoS One. 2024 Nov 11;19(11):e0309792. doi: 10.1371/journal.pone.0309792. eCollection 2024.
6
A 14-Year Analysis of Breast Cancer Risk Factors and Its Determinants of Mortality in Rural Southwestern Nigeria.尼日利亚西南部农村地区乳腺癌风险因素及其死亡率决定因素的14年分析。
Clin Med Insights Oncol. 2024 Nov 3;18:11795549241288197. doi: 10.1177/11795549241288197. eCollection 2024.
7
Pattern of burden cancer breast and relationshipin to human development index in Iran 2009 to 2019: an observational study based on the Global Burden of Diseases.2009 年至 2019 年伊朗乳腺癌负担模式及其与人类发展指数的关系:基于全球疾病负担的观察性研究
BMC Womens Health. 2024 Sep 27;24(1):540. doi: 10.1186/s12905-024-03378-4.
8
Mortality of Young Women due to Breast Cancer in Low, Middle and High-Income Countries: Systematic Literature Review and Meta-Analysis.低、中、高收入国家年轻女性因乳腺癌导致的死亡率:系统文献回顾和荟萃分析。
Asian Pac J Cancer Prev. 2024 Jul 1;25(7):2219-2227. doi: 10.31557/APJCP.2024.25.7.2219.
9
Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines.V9302(一种跨膜谷氨酰胺通量竞争性拮抗剂)对乳腺癌细胞系耐药逆转的影响
Pharmaceutics. 2024 Jun 29;16(7):877. doi: 10.3390/pharmaceutics16070877.
10
Systematic Review of Survival Outcomes of Pregnancy-Associated Breast Cancer in Asian Countries.亚洲国家妊娠相关乳腺癌生存结局的系统评价
Malays J Med Sci. 2024 Apr;31(2):6-17. doi: 10.21315/mjms2024.31.2.2. Epub 2024 Apr 23.